CNS Pharmaceuticals, Inc. (CNSP)
5.75
-0.19
(-3.20%)
USD |
NASDAQ |
Sep 09, 16:00
5.75
0.00 (0.00%)
After-Hours: 16:58
CNS Pharmaceuticals Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 3.287 |
| December 31, 2025 | 0.0727 |
| September 30, 2025 | 0.0031 |
| June 30, 2025 | 0.0093 |
| March 31, 2025 | 0.0192 |
| December 31, 2024 | 0.0528 |
| September 30, 2024 | 0.0093 |
| June 30, 2024 | -0.0287 |
| March 31, 2024 | -0.0481 |
| December 31, 2023 | -0.0679 |
| September 30, 2023 | -0.0241 |
| June 30, 2023 | 0.0678 |
| March 31, 2023 | 0.0828 |
| December 31, 2022 | 0.0504 |
| September 30, 2022 | 0.0047 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.0136 |
| March 31, 2022 | 0.0184 |
| December 31, 2021 | 0.0629 |
| September 30, 2021 | 0.0049 |
| June 30, 2021 | 0.0143 |
| March 31, 2021 | 0.0275 |
| December 31, 2020 | 0.0315 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 1500.00 |
| June 30, 2019 | 0.7943 |
| March 31, 2019 | -0.4057 |
| December 31, 2018 | -0.5769 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 21.94M |
| Total Liabilities (Quarterly) | 3.738M |
| Shareholders Equity (Quarterly) | 18.20M |
| Current Ratio | 5.845 |
| Net Debt Paydown Yield | 0.60% |